Neuroinflammation in Parkinson's disease
- PMID: 19821032
- PMCID: PMC3736976
- DOI: 10.1007/s11481-009-9176-0
Neuroinflammation in Parkinson's disease
Abstract
During the last two decades, a wealth of animal and human studies has implicated inflammation-derived oxidative stress and cytokine-dependent neurotoxicity in the progressive degeneration of the dopaminergic nigrostriatal pathway, the hallmark of Parkinson's disease (PD). In this review, we discuss the various hypotheses regarding the role of microglia and other immune cells in PD pathogenesis and progression, the inflammatory mechanisms implicated in disease progression from pre-clinical and clinical studies, the recent evidence that systemic inflammation can trigger microglia activation in PD-relevant central nervous system regions, the synergism between gene products linked to parkinsonian phenotypes (alpha-synuclein, parkin, Nurr1, and regulator of G-protein signaling-10) and neuroinflammation in promoting neurodegeneration of the nigrostriatal pathway, and the latest update on meta-analysis of epidemiological studies on the risk-lowering effects of anti-inflammatory drug regimens.
Figures
Similar articles
-
The Contribution of Microglia to Neuroinflammation in Parkinson's Disease.Int J Mol Sci. 2021 Apr 28;22(9):4676. doi: 10.3390/ijms22094676. Int J Mol Sci. 2021. PMID: 33925154 Free PMC article. Review.
-
Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.Int J Neurosci. 2015;125(10):717-25. doi: 10.3109/00207454.2014.982795. Epub 2015 May 22. Int J Neurosci. 2015. PMID: 25364880 Review.
-
Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.Toxicol Lett. 2017 Jan 4;265:30-37. doi: 10.1016/j.toxlet.2016.11.002. Epub 2016 Nov 16. Toxicol Lett. 2017. PMID: 27865851 Review.
-
Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.Neurobiol Dis. 2016 Sep;93:96-114. doi: 10.1016/j.nbd.2016.04.008. Epub 2016 May 2. Neurobiol Dis. 2016. PMID: 27151770 Free PMC article.
-
IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.Brain Behav Immun. 2019 Oct;81:630-645. doi: 10.1016/j.bbi.2019.07.026. Epub 2019 Jul 24. Brain Behav Immun. 2019. PMID: 31351185
Cited by
-
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease.Nat Genet. 2021 Jun;53(6):787-793. doi: 10.1038/s41588-021-00847-6. Epub 2021 May 6. Nat Genet. 2021. PMID: 33958783 Free PMC article.
-
Immunologic privilege in the central nervous system and the blood-brain barrier.J Cereb Blood Flow Metab. 2013 Jan;33(1):13-21. doi: 10.1038/jcbfm.2012.153. Epub 2012 Oct 17. J Cereb Blood Flow Metab. 2013. PMID: 23072749 Free PMC article. Review.
-
Prospects for cannabinoid therapies in basal ganglia disorders.Br J Pharmacol. 2011 Aug;163(7):1365-78. doi: 10.1111/j.1476-5381.2011.01365.x. Br J Pharmacol. 2011. PMID: 21545415 Free PMC article. Review.
-
Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease.Toxicol Appl Pharmacol. 2011 Nov 1;256(3):314-23. doi: 10.1016/j.taap.2011.07.021. Epub 2011 Aug 6. Toxicol Appl Pharmacol. 2011. PMID: 21846476 Free PMC article.
-
Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats.Adv Pharm Bull. 2015 Nov;5(4):463-9. doi: 10.15171/apb.2015.063. Epub 2015 Nov 30. Adv Pharm Bull. 2015. PMID: 26819917 Free PMC article.
References
-
- Aarnisalo P, Kim CH, Lee JW, Perlmann T. Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1. J Biol Chem. 2002;277:35118–35123. - PubMed
-
- Abbott RD, Ross GW, White LR, Sanderson WT, Burchfiel CM, Kashon M, Sharp DS, Masaki KH, Curb JD, Petrovitch H. Environmental, life-style, and physical precursors of clinical Parkinson’s disease: recent findings from the Honolulu-Asia Aging Study. J Neurol. 2003;250(Suppl 3):III30–39. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical